Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 2017 (2017), Article ID 6212910, 5 pages
https://doi.org/10.1155/2017/6212910

Research Article

Clinical and Mortality Risk Factors in Bloodstream Infections with Carbapenem-Resistant Enterobacteriaceae

Xiaopeng Li and Huan Ye

Department of Infectious Diseases, Fuxing Hospital, Capital Medical University, Beijing, China

Correspondence should be addressed to Huan Ye; yedahuan01@126.com

Received 21 July 2017; Revised 22 September 2017; Accepted 27 September 2017; Published 12 December 2017

Academic Editor: José Ramón Blanco

Copyright © 2017 Xiaopeng Li and Huan Ye. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Objective. To investigate the risk factors underlying the occurrence and mortality of bloodstream infections (BSIs) with carbapenem-resistant Enterobacteriaceae (CRE). Methods. Medical information was retrospectively analyzed from 148 cases of patients with Enterobacteriaceae BSIs at a medical center in China, between 2013 and 2015. Results. The 30-day mortality rate in the CRE group was 65.4%. Indwelling urethral catheterization, admission to the ICU, use of antibiotics within 30 days, and BSIs from the respiratory system were associated with CRE BSIs. Lung infection, abdominal infection, central venous catheterization, and use of hormones within 30 days were associated with mortality. Conclusion. The 30-day mortality rate of CRE BSIs was high. Lung infections, abdominal infections, central venous catheterization, and use of hormones within 30 days increased the mortality rate of Enterobacteriaceae BSIs.

1. Introduction

Recently, infections with drug-resistant bacterial strains have increased which poses a challenge for anti-infection treatments in the clinical context and has become a serious problem in the field of public health. The incidence of bloodstream infections is also increasing and has become a major cause of the occurrence of infectious diseases and deaths worldwide [1]. Bloodstream infections with multidrug-resistant Enterobacteriaceae account for 71.5% of all bloodstream infections with multidrug-resistant bacterial strains [2]. Carbapenem antibiotics are typically one of the most effective drug classes for the treatment of Enterobacteriaceae infections. However, carbapenem-resistant Enterobacteriaceae (CRE) has been identified recently within all Enterobacteriaceae spp. The CHINET monitoring results show that Klebsiella pneumoniae accounts for the majority of cases of CRE infections among the Enterobacteriaceae spp., with drug resistance rates to imipenem and meropenem > 10% [3]. Studies have shown that the mortality rate is significantly higher for CRE infections than for carbapenem-sensitive Enterobacteriaceae infections [4].

This study was a retrospective analysis of medical information on bloodstream infections with Enterobacteriaceae (mainly Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Enterobacter aerogenes) with intent to identify the risk factors and prognosis for CRE bloodstream infections.

2. Materials and Methods

2.1. Study Subjects

A total of 148 cases of bloodstream infections with Enterobacteriaceae that occurred during the period between January 2013 and October 2015 in Fuxing Hospital of Capital Medical University, China, were selected. Clinical information from the patients, including demographic data, underlying diseases, pathogen drug resistance and drug sensitivity analyses, history of medical institution admission, level of care (ward versus ICU), history of invasive surgery, and prognosis, was recorded and analyzed. The characteristics of each case were collected from the electronic medical record database, and the files of all patients were complete.

Inclusion criteria: On the day of collection of a positive blood culture specimen, the patient had a temperature ≥ 38°C or < 36°C in combination with chills, and the multiple blood culture results showed the same type of bacteria. Exclusion criteria: (1) blood culture test results showing two or more types of bacteria and (2) only one blood culture specimen was positive, whereas multiple subsequent blood culture results were negative or identified other types of pathogens.

This study conformed to the standards of medical ethics and was approved by the Ethics Committee of Fuxing Hospital of Capital Medical University.

2.2. Relevant Definitions

The microbiology laboratory in our hospital currently uses an FX200 automatic blood culture instrument (BACTE) and a WalkAway 40 automatic microbiological drug sensitivity analysis instrument (USA). The drug sensitivity results were determined according to the Clinical and Laboratory Standards Institute (CLSI, USA) standards [5]. The definition of CRE was resistance to imipenem, meropenem, or ertapenem [3]. Extensively drug-resistant (XDR) bacteria were defined based on nonsusceptibility to all antimicrobial agents except colistin and tigecycline [6, 7]. Long-term bedbound patients were defined as patients who were bedbound for more than 14 days and could not recover [7].

2.3. Statistical Methods

The data processing and analysis were performed using SPSS 21.0 statistical software. indicated that the difference was significant. Measurement data with a normal distribution are expressed using the mean ± standard deviation. Measurement data with a nonnormal distribution are expressed using the median. Significance testing for differences between groups was performed using the t-test (normal distribution) or rank sum test (nonnormal distribution). Significance testing for differences in count data between groups was performed using the χ² test. The multivariate analysis was performed using logistic regression.

3. Results

3.1. Demographic Data and Clinical Characteristics

This study involved a total of 148 cases of bloodstream infections with Enterobacteriaceae. The mean age of the patients was 69.1 (±19.2) years. Male patients accounted for 50.7% of the cases, and 20.3% of the patients were admitted to the ICU. Long-term bedbound patients accounted for 54.1% of the cases, and 62.2% of the patients had a medical institution admission history within 3 months. The bloodstream infections mainly originated from the urinary tract (28.4%) or respiratory system (25.0%) or were catheter related (22.3%). Patients who had prior use of broad-spectrum antibiotics within 30 days accounted for 43.2% of the cases. The total average length of hospital stay was 21.7 (±12.5) days. Patients with CRE infections accounted for 17.6% of the cases, and patients with XDR Enterobacteriaceae infections accounted for 4.0% of the cases.

The results of the univariate and multivariate analyses of risk factors related to CRE bloodstream infections are shown in Tables 1 and 2, respectively (the relevant factors listed in the tables were all conditions before the presence of the bloodstream infection). The logistic regression analysis revealed that indwelling urethral catheterization, admission to the ICU, CRE infection of the respiratory system, and prior use of broad-spectrum antibiotics within 30 days were independent risk factors for CRE bloodstream infections.

Table 1: Univariate analysis of the clinical characteristics of bloodstream infections caused by CRE and non-CRE.

Clinical characteristics
Bloodstream infections with Enterobacteriaceae, n (%)
value

CRE group (n = 26)
Non-CRE group (n = 122)

Gender (male)
16 (61.5)
59 (48.4)
0.222

Age > 60 years
22 (84.6)
83 (68.0)
0.091

Community acquired
0
30 (24.6)
0.005

Admission to the ICU
20 (76.9)
10 (8.2)
<0.001

Long-term bedbound
19 (73.1)
61 (50)
0.032

Medical institution admission history within 3 months
17 (65.4)
75 (61.5)
0.709

Underlying diseases

    Cardiovascular disease
19 (73.1)
54 (44.3)
0.008

    Cerebrovascular disease
21 (80.8)
57 (46.7)
0.002

    Chronic respiratory disease
6 (23.1)
9 (7.4)
0.040

    Chronic kidney disease
13 (50.0)
33 (27.0)
0.022

    Diabetes mellitus
9 (34.6)
44 (36.1)
0.889

    Malignant tumor
4 (15.4)
44 (36.1)
0.041

    Anemia
26 (100.0)
87 (71.3)
0.002

    Hypoalbuminemia
26 (100.0)
98 (80.3)
0.029

    Lung infection
22 (84.6)
61 (50.0)
0.001

    Urinary tract infection
12 (46.2)
62 (50.8)
0.666

    Abdominal infection
5 (19.2)
14 (11.5)
0.453

    Tracheotomy
12 (46.2)
21 (17.2)
0.001

    Liver dysfunction
13 (50.0)
24 (19.7)
0.001

Invasive surgery before infection

    Mechanical ventilation
18 (69.2)
12 (9.8)
<0.001

    Central venous catheterization
19 (73.1)
28 (23.0)
<0.001

    Indwelling urethral catheterization
25 (96.2)
45 (36.9)
<0.001

Sources of bloodstream infection

    Catheter related
10 (38.5)
23 (18.9)
0.029

    Respiratory system
11 (42.3)
26 (21.3)
0.025

    Urinary tract infection
0 (0)
42 (34.4)
<0.001

    Others
5 (19.2)
31 (25.4)
0.505

Prior use of broad-spectrum antibiotics within 30 days
25 (96.2)
39 (32.0)
<0.001

Combined fungal infection
10 (38.5)
10 (8.2)
<0.001

Prior use of glucocorticoids within 30 days
8 (30.8)
11 (9.0)
0.007

Total length of hospital stay
25.4 ± 11.1
21.0 ± 12.7
0.102

30-Day mortality rate
17 (65.4)
21 (17.2)
<0.001

48-Hour mortality rate
6 (23.1)
3 (2.5)
<0.001

ICU: intensive care unit; .

Table 2: Analysis of risk factors for CRE bloodstream infections (logistic regression analysis).

Risk factor
OR value
95% CI
value

Indwelling urethral catheterization
11.40
1.05 to 124.18
0.046

Admission to the ICU
9.42
2.14 to 41.50
0.003

Respiratory system source
8.95
1.73 to 46.38
0.009

Prior use of broad-spectrum antibiotics within 30 days
11.25
1.19 to 106.79
0.035

OR: odds ratio; 95% CI: 95% confidence interval; respiratory system source: bloodstream infection with Enterobacteriaceae from the respiratory system.

3.2. Analysis of Risk Factors for Mortality in Bloodstream Infections with Enterobacteriaceae

According to the comparison of the 30-day prognosis between groups, the 30-day mortality rate for bloodstream infections with Enterobacteriaceae was 25.7%. Univariate analysis indicated that community acquired, admission to the ICU, long-term bedbound, anemia, hypoalbuminemia, lung infection, abdominal infection, liver dysfunction, mechanic ventilation, central venous catheterization, indwelling urethral catheterization, sources of bloodstream infection from catheter related and urinary tract, antibiotics within 30 days, combined fungal infection, prior use of glucocorticoids within 30 days, and CRE infection were significantly associated with 30-day risk of mortality (Tables 3). A logistic regression analysis revealed that lung infection, abdominal infection, central venous catheterization, and prior use of glucocorticoids within 30 days were independently associated with mortality (Tables 4).

Table 3: Univariate analysis for predictors of mortality caused by bloodstream infections with Enterobacteriaceae.

Clinical characteristics
Bloodstream infections with Enterobacteriaceae, n (%)
value

Survival group (n = 110)
Mortality group (n = 38)

Gender (male)
55 (50.0)
20 (52.6)
0.780

Age
67.5 ± 20.0
73.9 ± 15.9
0.075

Community acquired
28 (25.5)
2 (5.3)
0.008

Admission to the ICU
10 (9.1)
20 (52.6)
<0.001

Long-term bedbound
50 (45.5)
30 (78.9)
<0.001

Medical institution admission history within 3 months
69 (62.7)
23 (60.5)
0.809

Underlying diseases

    Cardiovascular disease
51 (46.4)
22 (57.9)
0.220

    Cerebrovascular disease
54 (49.1)
24 (63.2)
0.134

    Chronic respiratory disease
12 (10.9)
3 (7.9)
0.827

    Chronic kidney disease
30 (27.3)
16 (42.1)
0.089

    Diabetes mellitus
38 (34.5)
15 (39.5)
0.585

    Malignant tumor
37 (33.6)
11 (28.9)
0.594

    Anemia
77 (70.0)
36 (94.7)
0.002

    Hypoalbuminemia
87 (79.1)
37 (97.4)
0.008

    Lung infection
53 (48.2)
30 (78.9)
0.001

    Urinary tract infection
60 (54.5)
14 (36.8)
0.060

    Abdominal infection
9 (8.2)
10 (26.3)
0.009

    Tracheotomy
22 (20.0)
11 (28.9)
0.253

    Liver dysfunction
20 (18.2)
17 (44.7)
0.001

Invasive surgery before infection

    Mechanic ventilation
10 (9.1)
20 (52.6)
<0.001

    Central venous catheterization
20 (18.2)
27 (71.1)
<0.001

    Indwelling urethral catheterization
41 (37.3)
29 (76.3)
<0.001

Sources of bloodstream infection

    Catheter related
19 (17.3)
14 (36.8)
0.012

    Respiratory system
25 (22.7)
12 (31.6)
0.277

    Urinary tract
39 (35.5)
3 (7.9)
0.001

    Others
27 (24.5)
9 (23.7)
0.915

Prior use of broad-spectrum antibiotics within 30 days
36 (32.7)
28 (73.7)
<0.001

Combined fungal infection
9 (8.2)
11 (28.9)
<0.001

Prior use of glucocorticoids within 30 days
4 (3.6)
15 (39.5)
0.007

CRE infection
9 (8.2)
17 (44.7)
<0.001

Total length of hospital stay
21.4 ± 13.2
22.7 ± 10.4
0.528

CRE: carbapenem-resistant Enterobacteriaceae; .

Table 4: Logistic regression analysis of risk factors for mortality in patients with Enterobacteriaceae bloodstream infections.

Risk factor
OR value
95% CI
value

Lung infection
6.62
1.86 to 23.61
0.004

Abdominal infection
11.15
2.54 to 48.92
0.001

Central venous catheterization
5.25
1.84 to 14.94
0.002

Prior use of glucocorticoids within 30 days
22.40
4.07 to 123.38
<0.001

OR: odds ratio; 95% CI: 95% confidence interval.

4. Discussion

Currently, the incidence of carbapenemase-producing Enterobacteriaceae is increasing. Data have shown that many countries have interregional spread or an endemic situation [8]. The results of this study showed that the 30-day mortality rate for CRE bloodstream infections reached 65.4%, which was significantly higher than the rate for non-CRE bloodstream infections (17.2%) or for CRE-infected patients in literature reports (26%–44%) [4]. To date, many studies have evaluated risk factors related to bloodstream infections with multidrug-resistant Enterobacteriaceae. For example, factors including admission to the ICU, length of hospital stay, history of use of broad-spectrum antibiotics, such as quinolones and cephalosporins, history of resistant strain colonization, indwelling urethral catheterization, and central venous catheterization have been considered independent risk factors for bloodstream infections with multidrug-resistant Enterobacteriaceae [4, 9]. The analytical results in this study showed that indwelling urethral catheterization, admission to the ICU, prior use of broad-spectrum antibiotics within 30 days, and CRE infection of the respiratory system were independent risk factors for CRE bloodstream infections. The first three factors are similar to previous reports. However, what is different from previous reports is that we identified CRE infection of the respiratory system as an independent risk factor for CRE bloodstream infections. Respiratory tract infection was the most common source of bloodstream infection in our study, likely because of a decreased capacity for bacterial clearance resulting from the altered lung tissue in severe chronic obstructive lung disease.

The results of this study on risk factors for death due to bloodstream infections with Enterobacteriaceae showed that lung infections, abdominal infections, central venous catheterization, and hormone use within 30 days were all independent risk factors for death due to bloodstream infections with Enterobacteriaceae. The study results showed that the mortality rate was significantly higher in the CRE group than in the non-CRE group. The high mortality associated with CRE bloodstream infections was partially attributed to host conditions, such as endogenous infections and invasive surgery. Additionally, the mortality rate was associated with a lack of timely and accurate antibiotic treatment for infection with drug-resistant bacterial strains or even no antibiotic treatment [10]. XDR strains accounted for 23% of the 26 cases of CRE infections in this study, which was similar to the 28% rate of XDR bacterial strains isolated from CRE infections reported in the literature [8]. This result indicated that approximately one-fourth of CRE infections might be XDR, which is associated with a high mortality rate.

During the analysis of mortality-related risk factors in patients with bloodstream Enterobacteriaceae infections in this study, CRE infection was a relevant but not an independent risk factor, which might be associated with the low overall number of cases.

In summary, CRE bloodstream infections have a high mortality rate, and treatment has poor clinical efficacy. The use of broad-spectrum antibiotics, indwelling urethral catheterization, admission to the ICU, and infection from the respiratory system were independent risk factors for CRE bloodstream infections. Lung infections, abdominal infections, hormone use, and central venous catheterization were independent risk factors for death in patients with Enterobacteriaceae bloodstream infections. Therefore, the standard use of antibiotics, minimization of invasive operations, use of strict aseptic manipulation, and strengthening of hand-hygiene awareness of healthcare workers may be effective measures for the prevention of CRE bloodstream infections.

Conflicts of Interest

The authors declare that there are no conflicts of interest.

References

K. B. Laupland and D. L. Church, “Population-based epidemiology and microbiology of community-onset bloodstream infections,” Clinical Microbiology Reviews, vol. 27, no. 4, pp. 647–664, 2014.

R. Picot-Guéraud, P. Batailler, Y. Caspar, A. Hennebique, and M. R. Mallaret, “Bacteremia caused by multidrug-resistant bacteria in a French university hospital center: 3 years of collection,” American Journal of Infection Control, vol. 43, no. 9, pp. 960–964, 2015.

F. Hu, D. Zhu, F. Wang et al., “CHINET 2014 surveillance of bacterial resistance in China,” Chinese Journal of Infection and Chemotherapy, vol. 1, pp. 401–410, 2015.

M. E. Falagas, G. S. Tansarli, D. E. Karageorgopoulos, and K. Z. Vardakas, “Deaths attributable to carbapenem-resistant Enterobacteriaceae infections,” Emerging Infectious Diseases, vol. 20, no. 7, pp. 1170–1175, 2014.

F. Cockerill, M. Wikler, K. Bush et al., Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement, M100–S20, Clinical Laboratory Standards Institute (CLSI), Wayne, PA, USA, 2010.

A. P. Magiorakos, A. Srinivasan, R. B. Carey et al., “Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance,” Clinical Microbiology and Infection, vol. 18, no. 3, pp. 268–281, 2012.

M. Ferrall, New Definition of Bedridden in a RCFE, RCFE Legislative Updates and Public Policy, 2011.

S. Lofmark, K. Sjöström, B. Mäkitalo, P. Edquist, K. Tegmark Wisell, and C. G. Giske, “Carbapenemase-producing Enterobacteriaceae in Sweden 2007–2013: experiences from seven years of systematic surveillance and mandatory reporting,” Drug Resistance Updates, vol. 20, pp. 29–38, 2015.

J. C. Gallagher, S. Kuriakose, K. Haynes, and P. Axelrod, “Case-case-control study of patients with carbapenem-resistant and third-generation-cephalosporin-resistant Klebsiella pneumoniae bloodstream infections,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 10, pp. 5732–5735, 2014.

M. Falcone, A. Vena, M. L. Mezzatesta et al., “Role of empirical and targeted therapy in hospitalized patients with bloodstream infections caused by ESBL-producing Enterobacteriaceae,” Annali di Igiene: Medicina Preventiva e di Comunita, vol. 26, no. 4, pp. 293–304, 2014.